Stada’s Acquisition Spree Continues With Deal For Ukrainian Probiotics Player

Germany's Stada will gain a range of probiotics and other OTC brands through the acquisition of Ukraine's Biopharma. The deal is Stada's third in the space of just one month. 

Magnifying glass with the Map of Ukraine with a blue pushpin stuckMap of Ukraine with a blue pushpin stuck

Stada Arzneimittel AG’s recent acquisition spree is continuing as the German firm’s private-equity backers seek to bolster its footprint in the growth markets of Eastern Europe.

The company said it was poised to become a major player in Ukraine through the acquisition of Biopharma’s pharmaceutical prescription...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography